Description |
aggrecan |
tenascin R |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Attention deficit hyperactivity disorder ( 30563984)
- Body mass index ( 26426971)
- Corneal astigmatism ( 29422769)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Liver fibrosis in non-alcoholic fatty acid liver disease ( 31311600)
- Telomere length ( 30185882)
- Tonometry ( 17903302)
|
Interacting Genes |
17 interacting genes:
ADAMTS1
ADAMTS4
ADAMTS5
CTSB
FBLN1
FBLN2
HAPLN1
LUM
MMP1
MMP14
MMP19
MMP2
MMP20
MMP3
MMP8
TNFAIP6
TNR
|
15 interacting genes:
ACAN
BCAN
CCDC146
CNTN1
LGALS14
MAGEB4
NCAN
NCK2
NFASC
NTAQ1
POLR3C
PSMA1
PTPRZ1
SIGLEC1
VCAN
|
Entrez ID |
176 |
7143 |
HPRD ID |
01123 |
03589 |
Ensembl ID |
ENSG00000157766
|
ENSG00000116147
|
Uniprot IDs |
P16112
|
A1L306
Q92752
|
PDB IDs |
4MD4
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|